← BackKlaviyo, Inc. · SoftwareKVYO
Low riskNext report: In 7 days (est.)
The short versionA company still losing money with growing sales.
Going well
- Sales up 26% in the latest quarter vs a year ago
- Sales up 32% last year
- No debt reported
Watch out for
- Losing money
- Share count growing 8.2% a year
Money moves
- Insiders sold $1.7M in the last 30 days, all through pre-planned sales
- Institutions cut 8% from their holdings in the quarter ending June 2026 (166 bought, 130 sold)
Facts from SEC filings, not a recommendation.
What the price means
Price as of Oct 26
$20.70-2.0% that day
- Company value
- $6.1B
- Share price times all shares
- Price vs sales
- 4.4x
- No profit over the last year, so this compares value with sales instead
- Cash vs value
- 14%
- Cash as a share of company value
From KVYO's last IEX trade and its SEC filings (profits and sales over the last four quarters). A starting point for research, not a verdict.
The business over time
Last 12 quarters, from SEC filings
Sales, Jun '26$370.6M+26% vs a year earlier
Sep '23Tap a barJun '26
Last 12 months: $1.4B, up 29% from the 12 months before.
Business quality
The checklist Warren Buffett-style investors use. Annual numbers for 2025.- MissReturn on equity 15%+Earns a lot on the money owners have in the business.-2.8%
- PassDebt under half of equityNot relying on borrowed money.No debt reported
- MissNet margin 10%+Keeps at least 10 cents of profit from each dollar of sales.-2.6%
- MissProfitable every yearSteady profits, not one good year.0 of 5 years
- PassFree cash flow positiveBrings in more cash than it spends to run and grow.$208.5M
- MissShare count not growingNot diluting owners. Falling means buybacks.+26.6% in 3 years
- PassGross margin 40%+Pricing power: sells for well above what it costs to make.74.7%
- Revenue
- $1.2B
- +31.6% vs prior year
- Total debt
- None
- 0.00x equity
- Current ratio
- 4.27x
- short-term assets / bills due
- Free cash flow
- $208.5M
- 16.9% of revenue
From annual reports filed with the SEC. A checklist is a starting point for research, not a verdict.
Latest quarter
Quarter ended Jun 30, 2026- Revenue
- $370.6M
- +26.4% YoY
- EPS
- -$0.03
- vs -$0.09
- Op. margin
- -4.0%
- +6.7 pts
- Gross margin
- 72.6%
- -3.1 pts
- Free cash flow
- $87.3M
- Share count
- +4.2%
- vs a year ago
Insider rating
Last 90 days
44Mixed
- Pre-planned sales of $1.7M (weaker signal)
50 is neutral. Buying by more insiders, top executives and bigger stakes raises it. Selling lowers it; pre-planned sales count less.
Weekly insider trend13 weeks agoBoughtSoldThis week
Filing buzz
Last 7 days vs normal
0/ 100
- This week
- 0
- Normal week
- 2.6
- vs normal
- 0.0x
SEC filings of any kind. 50 means a normal week.
Institutional ownership
■Steady-8.0%Institutions cut 8.0% from their holdings. 166 bought, 130 sold. 2 quarters of net selling in a row.
Shares held by institutions145.3M
Sep '24Jun '26
Share count growthYearly rate, last 3 years
+3.4%Cash runwayAt last year's cash burn
Cash flow positiveDebt to equityLatest balance sheet: debt compared with what owners have
No debt reportedShares outstandingLatest reported
297MNext reportIn 7 days (est.)Estimated from the same quarter last year
- Results filedAug 5
- Results filedMay 5
- Results filedFeb 10
- Results filedNov 5, 2025
- Results filedAug 5, 2025
Insider trades
Open-market buys and sells, last 90 days Bought$00 insiders
Sold$1.7M1 insider, 2 pre-planned
| Insider | Trade | Shares | Avg price | Value | Owns after | Date |
|---|
Ed HallenDirector | Sell | 97K | $17.40 | $1.7M | 388K | |
- -20.1% of their holdings
- 2 trades
- Held via Hodgkins LLC
- Pre-planned sale (10b5-1)
- Also 10% owner
- Filed 2 days after
|
Ed HallenDirector | Sell | 1K | $17.02 | $22K | 447K | |
- -0.3% of their holdings
- 2 trades
- Held via Hodgkins LLC
- Pre-planned sale (10b5-1)
- Also 10% owner
- Filed 1 day after
|
"Owns after" is the insider's holding right after the trade. Pre-planned (10b5-1) sales are set up months ahead, a weaker signal.
Latest filings
Straight from SEC EDGAR
SoldEd HallenDirector, 10% owner
97,482 shares at $17.40 · $1.7M
- -20% of holdings
- Now owns 388,131 shares
- Pre-planned sale (10b5-1)
- Held by Hodgkins Trust
- 2 transactions
- Filed 2 days after trade
- Also: Gift
Planned insider saleOct 7 · Form 144 ↗SoldEd HallenDirector, 10% owner
1,300 shares at $17.02 · $22K
- -0% of holdings
- Now owns 446,946 shares
- Pre-planned sale (10b5-1)
- Held by Hodgkins Trust
- 2 transactions
- Filed 1 day after trade
Planned insider saleSep 24 · Form 144 ↗Planned insider saleSep 17 · Form 144 ↗Stock awardErica Ellen SmithChief Financial Officer
1,150,684 shares
- Now owns 1,150,684 shares
- 2 transactions
- Filed 2 days after trade
SoldLedger Susan St.Director
2,328 shares at $15.93 · $37K
- -9% of holdings
- Now owns 23,433 shares
- Pre-planned sale (10b5-1)
- Filed 3 days after trade
Planned insider saleSep 11 · Form 144 ↗SoldLandon EdmondChief Legal Officer
61,576 shares at $20.07 avg ($20.01 to $20.44) · $1.2M
- -11% of holdings
- Now owns 477,866 shares
- Pre-planned sale (10b5-1)
- 2 transactions
- Filed 1 day after trade
SoldEd HallenDirector, 10% owner
98,782 shares at $20.48 avg ($20.47 to $20.49) · $2.0M
- -18% of holdings
- Now owns 465,631 shares
- Pre-planned sale (10b5-1)
- Held by Hodgkins Trust
- 2 transactions
- Filed 1 day after trade
- Also: Gift
New insiderSep 1 · Form 3 ↗Planned insider saleAug 31 · Form 144 ↗Planned insider saleAug 31 · Form 144 ↗Insider tradeAug 31 · Form 4 ↗5%+ holder update (active)Aug 31 · Form SCHEDULE 13D/A ↗